MENU
+Compare
TNYA
Stock ticker: NASDAQ
AS OF
Apr 24, 02:58 PM (EDT)
Price
$0.46
Change
+$0.01 (+2.22%)
Capitalization
73.97M

TNYA Tenaya Therapeutics Forecast, Technical & Fundamental Analysis

Tenaya Therapeutics Inc is a preclinical stage biotechnology company focused on discovering, developing, and delivering curative therapies that address the underlying drivers of heart disease... Show more

TNYA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for TNYA with price predictions
Apr 23, 2025

TNYA in -1.79% downward trend, falling for three consecutive days on April 23, 2025

Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where TNYA declined for three days, in of 253 cases, the price declined further within the following month. The odds of a continued downward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Aroon Indicator for TNYA entered a downward trend on April 21, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where TNYA's RSI Indicator exited the oversold zone, of 31 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 45 cases where TNYA's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on April 23, 2025. You may want to consider a long position or call options on TNYA as a result. In of 55 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for TNYA just turned positive on April 11, 2025. Looking at past instances where TNYA's MACD turned positive, the stock continued to rise in of 34 cases over the following month. The odds of a continued upward trend are .

TNYA may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.797) is normal, around the industry mean (14.056). P/E Ratio (0.000) is within average values for comparable stocks, (63.446). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.788). Dividend Yield (0.000) settles around the average of (0.025) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (252.992).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. TNYA’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. TNYA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
TNYA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

TNYA is expected to report earnings to fall 31.75% to -19 cents per share on May 07

Tenaya Therapeutics TNYA Stock Earnings Reports
Q1'25
Est.
$-0.19
Q4'24
Beat
by $0.03
Q3'24
Beat
by $0.07
Q2'24
Beat
by $0.05
Q1'24
Beat
by $0.02
The last earnings report on March 10 showed earnings per share of -28 cents, beating the estimate of -31 cents. With 674.46K shares outstanding, the current market capitalization sits at 73.97M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
171 Oyster Point Boulevard
Phone
+1 650 825-6990
Employees
140
Web
https://www.tenayatherapeutics.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ACMR19.731.28
+6.94%
ACM Research
META520.2719.99
+4.00%
Meta Platforms
NVNO2.700.09
+3.45%
enVVeno Medical Corp
AMLX5.060.14
+2.85%
Amylyx Pharmaceuticals
MMYT103.09-1.06
-1.02%
MakeMyTrip Limited

TNYA and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, TNYA has been loosely correlated with VCYT. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if TNYA jumps, then VCYT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TNYA
1D Price
Change %
TNYA100%
-1.06%
VCYT - TNYA
40%
Loosely correlated
+1.08%
ABSI - TNYA
36%
Loosely correlated
-0.47%
RCUS - TNYA
34%
Loosely correlated
+0.25%
OPT - TNYA
33%
Poorly correlated
N/A
FATE - TNYA
32%
Poorly correlated
-2.55%
More